Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition

ObjectiveThis article investigates the role of Transgelin (TAGLN) in the epithelial–mesenchymal transition (EMT) of esophageal squamous cell carcinomas (ESCC) and its possible mechanism of inhibiting the invasion of these cancers.MethodsTissue specimens and clinical information of patients with ESCC...

Full description

Bibliographic Details
Main Authors: Boli Yang, Qiuyu Chen, Changshan Wan, Siyuan Sun, Lanping Zhu, Zhizhong Zhao, Weilong Zhong, Bangmao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.709486/full
_version_ 1828858914629746688
author Boli Yang
Boli Yang
Qiuyu Chen
Changshan Wan
Siyuan Sun
Lanping Zhu
Zhizhong Zhao
Weilong Zhong
Bangmao Wang
author_facet Boli Yang
Boli Yang
Qiuyu Chen
Changshan Wan
Siyuan Sun
Lanping Zhu
Zhizhong Zhao
Weilong Zhong
Bangmao Wang
author_sort Boli Yang
collection DOAJ
description ObjectiveThis article investigates the role of Transgelin (TAGLN) in the epithelial–mesenchymal transition (EMT) of esophageal squamous cell carcinomas (ESCC) and its possible mechanism of inhibiting the invasion of these cancers.MethodsTissue specimens and clinical information of patients with ESCC were collected to analyze the relationship between Transgelin expression level and prognosis of patients with ESCC. Transgelin siRNA was used to knock down Transgelin expression. The expression of Transgelin in Eca-109 and KYSE-150 cells was overexpressed by Transgelin-overexpressing plasmid. The effects of Transgelin overexpression and knockdown on the proliferation of Eca-109 and KYSE-150 cells were examined by Transwell chamber, scratch assay, and CCK-8 cell activity assay. RT-PCR and Western blot were used to detect the effect of Transgelin overexpression or knockdown on the mRNA and protein expressions of E-cadherin and Vimentin. TCGA data were used to analyze Transgelin co-expressed genes and further study the GO and KEGG enrichment analysis results under the influence of Transgelin.ResultsThe expression of Transgelin was low in ESCC, and its expression level was positively correlated with the prognosis of patients with ESCC. The targeted Transgelin siRNA and Transgelin-overexpressing plasmid can effectively regulate the expression of Transgelin mRNA and protein in Eca-109 and KYSE-150 cells. After overexpression of Transgelin, the invasion and proliferation abilities of Eca-109 and KYSE-150 cells were significantly decreased compared with those of the control group (P < 0.05). However, Transgelin knockdown could promote the proliferation, migration, and invasion of ESCC cells. The overexpression of Transgelin inhibits EMT in ESCC. With the increase of Transgelin expression in Eca-109 and KYSE-150 cells, the expression of E-cadherin increased, while the expression of Vimentin decreased, and the difference was statistically significant (P < 0.05).ConclusionTransgelin can inhibit the malignant progression of ESCC by inhibiting the occurrence of EMT.
first_indexed 2024-12-13T02:07:08Z
format Article
id doaj.art-dbd02eef43ad4abdbb644ba5f0eda6b5
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-13T02:07:08Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-dbd02eef43ad4abdbb644ba5f0eda6b52022-12-22T00:03:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-08-011110.3389/fonc.2021.709486709486Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal TransitionBoli Yang0Boli Yang1Qiuyu Chen2Changshan Wan3Siyuan Sun4Lanping Zhu5Zhizhong Zhao6Weilong Zhong7Bangmao Wang8Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, ChinaDepartment of Digestive Diseases, Jincheng General Hospital, Shanxi, ChinaDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, ChinaDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, ChinaDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, ChinaDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, ChinaDepartment of Digestive Diseases, Jincheng General Hospital, Shanxi, ChinaDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, ChinaDepartment of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, ChinaObjectiveThis article investigates the role of Transgelin (TAGLN) in the epithelial–mesenchymal transition (EMT) of esophageal squamous cell carcinomas (ESCC) and its possible mechanism of inhibiting the invasion of these cancers.MethodsTissue specimens and clinical information of patients with ESCC were collected to analyze the relationship between Transgelin expression level and prognosis of patients with ESCC. Transgelin siRNA was used to knock down Transgelin expression. The expression of Transgelin in Eca-109 and KYSE-150 cells was overexpressed by Transgelin-overexpressing plasmid. The effects of Transgelin overexpression and knockdown on the proliferation of Eca-109 and KYSE-150 cells were examined by Transwell chamber, scratch assay, and CCK-8 cell activity assay. RT-PCR and Western blot were used to detect the effect of Transgelin overexpression or knockdown on the mRNA and protein expressions of E-cadherin and Vimentin. TCGA data were used to analyze Transgelin co-expressed genes and further study the GO and KEGG enrichment analysis results under the influence of Transgelin.ResultsThe expression of Transgelin was low in ESCC, and its expression level was positively correlated with the prognosis of patients with ESCC. The targeted Transgelin siRNA and Transgelin-overexpressing plasmid can effectively regulate the expression of Transgelin mRNA and protein in Eca-109 and KYSE-150 cells. After overexpression of Transgelin, the invasion and proliferation abilities of Eca-109 and KYSE-150 cells were significantly decreased compared with those of the control group (P < 0.05). However, Transgelin knockdown could promote the proliferation, migration, and invasion of ESCC cells. The overexpression of Transgelin inhibits EMT in ESCC. With the increase of Transgelin expression in Eca-109 and KYSE-150 cells, the expression of E-cadherin increased, while the expression of Vimentin decreased, and the difference was statistically significant (P < 0.05).ConclusionTransgelin can inhibit the malignant progression of ESCC by inhibiting the occurrence of EMT.https://www.frontiersin.org/articles/10.3389/fonc.2021.709486/fullesophageal squamous cell carcinoma (ESCC)transgelinepithelial mesenchymal transition (EMT)invasionmetastasisproliferation
spellingShingle Boli Yang
Boli Yang
Qiuyu Chen
Changshan Wan
Siyuan Sun
Lanping Zhu
Zhizhong Zhao
Weilong Zhong
Bangmao Wang
Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
Frontiers in Oncology
esophageal squamous cell carcinoma (ESCC)
transgelin
epithelial mesenchymal transition (EMT)
invasion
metastasis
proliferation
title Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
title_full Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
title_fullStr Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
title_full_unstemmed Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
title_short Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
title_sort transgelin inhibits the malignant progression of esophageal squamous cell carcinomas by regulating epithelial mesenchymal transition
topic esophageal squamous cell carcinoma (ESCC)
transgelin
epithelial mesenchymal transition (EMT)
invasion
metastasis
proliferation
url https://www.frontiersin.org/articles/10.3389/fonc.2021.709486/full
work_keys_str_mv AT boliyang transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT boliyang transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT qiuyuchen transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT changshanwan transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT siyuansun transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT lanpingzhu transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT zhizhongzhao transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT weilongzhong transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition
AT bangmaowang transgelininhibitsthemalignantprogressionofesophagealsquamouscellcarcinomasbyregulatingepithelialmesenchymaltransition